ABOUT OUR PRESENTATIONS
NOVEL Health Strategies team is presenting 16 studies at ISPOR Annual Meeting in Milan, Italy on market access strategy, pricing and health economic and outcomes research trends.
These studies were led by Novel Health team and are good examples of wide breadth and depth of our expertise.
In-person replays of all presentations are available upon request.
Two of our Presentations Won ISPOR's Poster Award Finalist Honor.
Download PDFs of some of the already released presentations
IMPACT OF ESSENTIAL HEALTH BENEFITS ON US MARKET ACCESS (PDF)
NETWORK META-ANALYSIS ON PREVENTION OF STROKE FOR PATENT FORAMEN OVALE CLOSURE (PDF)
POLICY IMPLICATIONS OF AFFORDABLE CARE ACT ON US MARKET ACCESS (PDF)
HEOR PRESENTATIONS
PCV129: SYSTEMATIC REVIEW OF HYPERKALEMIA DUE TO ANGIOTENSIN ENZYME CONVERTING INHIBITORS
PCV12: NETWORK META-ANALYSIS TO ASSESS COMPARATIVE EFFECTIVENESS OF BETA-BLOCKERS IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION
PCV75: TRENDS IN EMERGENCY ROOM VISITS DUE TO HYPERKALEMIA IN THE UNITED STATES
PSS63: REVIEW OF PATIENT REPORTED OUTCOMES IN GLAUCOMA
PCN50: SYSTEMATIC REVIEW OF BURDEN OF CUTANEOUS T-CELL LYMPHOMA
PMD16: NETWORK META-ANALYSIS ON PREVENTION OF STROKE FOR PATENT FORAMEN OVALE CLOSURE
PCN56: SYSTEMATIC REVIEW OF BURDEN OF PANCREATIC CANCER
PSY10: COMPARISON OF NETWORK META-ANALYSIS AND TRADITIONAL META-ANALYSIS FOR PREVENTION OF RELAPSES IN MULTIPLE SCLEROSIS
PIN6: PROBIOTICS SIGNIFICANTLY REDUCE MORTALITY IN PRETERM NEWBORNS WITH NECROTISING ENTEROCOLITIS: RESULTS OF LARGE NETWORK META-ANALYSIS
PRICING AND MARKET ACCESS
PHP155: SYSTEMATIC REVIEW OF FDA BREAKTHROUGH THERAPY DESIGNATED PRODUCTS
PHP21: POLICY IMPLICATIONS OF AFFORDABLE CARE ACT ON US MARKET ACCESS
PHP187: IMPACT OF ESSENTIAL HEALTH BENEFIT BENCHMARK PLANS ON US MARKET ACCESS
PHP189: ULTRA ORPHAN AND CANCER DRUG PRICING TRENDS IN THE US AND THE UK
PHP107: SYSTEMATIC REVIEW OF COST EFFECTIVENESS OF ULTRA-ORPHAN THERAPIES
PHP184: OVERVIEW OF NUB PROCESS FOR IN-PATIENT DRUGS AND DEVICES IN GERMANY
PHP11: SYSTEMATIC REVIEW ON USE OF ECONOMIC EVIDENCE IN CLINICAL GUIDELINES